The interaction with GSK goes deeper, with Novartis and GSK announcing a merger of their OTC divisions to create a new joint venture which will be number one in the sector. This mirrors an earlier ...

Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer ...

GlaxoSmithKline was formerly called GlaxoWelcome before its merger with U.S. pharmaceutical company SmithKline Beecham in 2000. The combination has made GlaxoSmithKline the 6th largest ...

While some commentators expect Read to try for another big merger before he steps down ... fell through after bidders Reckitt Benckiser and GlaxoSmithKline pulled out. The company reported ...

Newspapers have jumped on this by suggesting that GSK is stalking American Home Products, a previous SmithKline merger target and a company with a strong drug pipeline. But chief executive officer ...

Consumer health goods group Haleon has appointed Jo Cooper as the new General Manager for its operations in the UK and Ireland.